Amedeo Smart

Free Medical Literature Service


 

Amedeo

Arrhythmias

  Free Subscription

Articles published in
J Cardiol
    February 2024
  1. SUGAWARA M, Kondo Y, Ryuzaki S, Yoshino Y, et al
    Long-term prognosis and prognostic factors after primary prophylactic implantable cardioverter-defibrillator therapy.
    J Cardiol. 2024 Feb 19:S0914-5087(24)00024-8. doi: 10.1016/j.jjcc.2024.
    >> Share

    December 2023
  2. TOMSIC A, Meucci MC, de Jong AR, Braun J, et al
    Mitral regurgitation in atrial fibrillation: Is a simple repair enough to tackle a complex problem?
    J Cardiol. 2023 Dec 14:S0914-5087(23)00295-2. doi: 10.1016/j.jjcc.2023.
    >> Share

    November 2023
  3. YAMAMOTO T, Nambu Y, Bo R, Morichi S, et al
    Electrocardiographic R wave amplitude in V6 lead as a predictive marker of cardiac dysfunction in Duchenne muscular dystrophy.
    J Cardiol. 2023;82:363-370.
    >> Share

  4. NARUMI T, Naruse Y, Miyajima K, Kaneko Y, et al
    Actual conditions of atrial septal lead implantation and the factors related to successful implantation.
    J Cardiol. 2023;82:371-377.
    >> Share

    October 2023
  5. WENG CJ, Li CH, Lin YJ, Chang SL, et al
    Skin Sympathetic Nerve Activity in Different Ablation Settings for Atrial Fibrillation.
    J Cardiol. 2023 Oct 12:S0914-5087(23)00247-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  6. HARA H, Kubo S, Nakajima Y, Matsumoto T, et al
    Initial results of transcatheter modification of left atrial appendage by obliteration with device in patients with nonvalvular atrial fibrillation: Real-world data from the TERMINATOR registry.
    J Cardiol. 2023 Oct 5:S0914-5087(23)00240-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  7. NAKATSUKASA T, Ishizu T, Minami K, Kawamatsu N, et al
    Reverse remodeling of the tricuspid valve complex by sinus rhythm restoration after catheter ablation.
    J Cardiol. 2023;82:248-256.
    >> Share

    September 2023
  8. NAGASE T, Kikuchi T, Unno T, Arai R, et al
    Impedance-guided modified CLOSE protocol ablation can reduce ablation index necessary for pulmonary vein isolation in patients with atrial fibrillation.
    J Cardiol. 2023 Sep 7:S0914-5087(23)00224-1. doi: 10.1016/j.jjcc.2023.
    >> Share

    August 2023
  9. ECKMAN MH, Wise R, Knochelmann C, Mardis R, et al
    Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?
    J Cardiol. 2023 Aug 12:S0914-5087(23)00191-0. doi: 10.1016/j.jjcc.2023.
    >> Share

  10. KHALID SI, Sathianathan S, Thomson KB, McGuire LS, et al
    5-year Stroke Rates in Nonvalvular Atrial Fibrillation after Watchman compared to Direct Oral Anticoagulants.
    J Cardiol. 2023 Aug 2:S0914-5087(23)00181-8. doi: 10.1016/j.jjcc.2023.
    >> Share

  11. IMAMURA S, Miyata M, Tagata K, Yokomine T, et al
    Prognostic predictors in patients with cardiopulmonary arrest: A novel equation for evaluating the 30-day mortality.
    J Cardiol. 2023;82:146-152.
    >> Share

    July 2023
  12. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Left atrial appendage peak flow velocity predicts improvement in mitral regurgitation after atrial fibrillation ablation.
    J Cardiol. 2023 Jul 19:S0914-5087(23)00165-X. doi: 10.1016/j.jjcc.2023.
    >> Share

  13. OKAMOTO H, Miyake M, Hayashi A, Matsutani H, et al
    Differences in clinical and echocardiographic features and outcomes between atrial functional mitral regurgitation patients with and without posterior mitral leaflet bending.
    J Cardiol. 2023;82:22-28.
    >> Share

  14. NAKAGAWA S, Takahama H, Hoshino K, Yanagi Y, et al
    Prevalence and predictive factors for clinical outcomes of isolated functional tricuspid regurgitation.
    J Cardiol. 2023;82:8-15.
    >> Share

    June 2023
  15. KAWAKAMI H, Saito M, Fujisawa T, Nagai T, et al
    A cost-effectiveness analysis of remote monitoring after pacemaker implantation for bradycardia in Japan.
    J Cardiol. 2023 Jun 19:S0914-5087(23)00139-9. doi: 10.1016/j.jjcc.2023.
    >> Share

  16. KITAHARA H, Yamashita D, Sato T, Suzuki S, et al
    Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention.
    J Cardiol. 2023 Jun 17:S0914-5087(23)00138-7. doi: 10.1016/j.jjcc.2023.
    >> Share

    May 2023
  17. KATAOKA N, Imamura T
    Prognostic impact of xanthine oxidoreductase activity in patients with heart failure and atrial fibrillation.
    J Cardiol. 2023 May 24:S0914-5087(23)00115-6. doi: 10.1016/j.jjcc.2023.
    >> Share

  18. HAMEED I, Malik S, Nusrat K, Siddiqui OM, et al
    Effect of vitamin D on postoperative atrial fibrillation in patients who underwent coronary artery bypass grafting: A systematic review and Meta-analysis.
    J Cardiol. 2023 May 24:S0914-5087(23)00113-2. doi: 10.1016/j.jjcc.2023.
    >> Share

  19. TOGASHI I, Sato T
    Conduction system pacing: Current status and prospects.
    J Cardiol. 2023;81:413-419.
    >> Share

    April 2023
  20. SEGEV A, Maor E, Goldenfeld M, Itelman E, et al
    Atrial fibrillation in young hospitalized patients: clinical characteristics, predictors of new onset, and outcomes.
    J Cardiol. 2023 Apr 26:S0914-5087(23)00096-5. doi: 10.1016/j.jjcc.2023.
    >> Share

    March 2023
  21. CHOW JK, Bagai A, Tan MK, Har BJ, et al
    Antithrombotic Therapies in Canadian Atrial Fibrillation Patients with Concomitant Coronary Artery Disease: Insights from the CONNECT AF+PCI-II Program.
    J Cardiol. 2023 Mar 15:S0914-5087(23)00052-7. doi: 10.1016/j.jjcc.2023.
    >> Share

  22. BUKHARI S, Khan B
    Prevalence of Ventricular Arrhythmias and Role of Implantable Cardioverter-Defibrillator in Cardiac Amyloidosis.
    J Cardiol. 2023 Mar 7:S0914-5087(23)00048-5. doi: 10.1016/j.jjcc.2023.
    >> Share

  23. TERASAKA N, Spanopoulos D, Miyagoshi H, Kubo T, et al
    Estimating the prevalence, clinical characteristics, and treatment patterns of hypertrophic cardiomyopathy in Japan: A nationwide medical claims database study.
    J Cardiol. 2023;81:316-322.
    >> Share

    February 2023
  24. MIYAZAKI Y, Yamagata K, Wakamiya A, Shimamoto K, et al
    Adding interactive face-to-face lectures to passive lectures effectively reduces radiation exposure during atrial fibrillation ablation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00044-8. doi: 10.1016/j.jjcc.2023.
    >> Share

  25. YANO M, Egami Y, Kawanami S, Sugae H, et al
    Relationship between pre-procedural non-ischemic ST-segment depression and the clinical outcomes after catheter ablation in persistent atrial fibrillation patients.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00043-6. doi: 10.1016/j.jjcc.2023.
    >> Share

  26. WATANABE K, Arimoto T, Watanabe T, Otaki Y, et al
    Prognostic impact of plasma xanthine oxidoreductase activity in patients with heart failure with atrial fibrillation.
    J Cardiol. 2023 Feb 21:S0914-5087(23)00042-4. doi: 10.1016/j.jjcc.2023.
    >> Share

  27. LI M, Ma W, Fan F, Yi T, et al
    Renal denervation in management of heart failure with reduced ejection fraction: A systematic review and meta-analysis.
    J Cardiol. 2023 Feb 7:S0914-5087(23)00021-7. doi: 10.1016/j.jjcc.2023.
    >> Share

  28. KATAOKA N, Imamura T, Uchida K, Koi T, et al
    Urgent catheter ablation in Japanese patients with mechanical circulatory supports suffering from refractory ventricular electrical storm.
    J Cardiol. 2023;81:229-235.
    >> Share

    January 2023
  29. WADA H, Miyauchi K, Suwa S, Miyazaki S, et al
    Impact of atrial fibrillation type (paroxysmal vs. non-paroxysmal) on long-term clinical outcomes: The RAFFINE registry subanalysis.
    J Cardiol. 2023 Jan 12:S0914-5087(22)00331-8. doi: 10.1016/j.jjcc.2022.
    >> Share

  30. NAKAHARA S
    Catheter ablation of ventricular tachycardia associated with structural heart disease: Current status and perspectives.
    J Cardiol. 2023;81:57-62.
    >> Share

    December 2022
  31. GASSANOV N, Mutallimov M, Caglayan E, Erdmann E, et al
    ECG as a risk stratification tool in patients with wearable cardioverter-defibrillator.
    J Cardiol. 2022;80:573-577.
    >> Share

    November 2022
  32. IKEDA T, Yamashita T, Akao M, Atarashi H, et al
    Prognostic impact of heart rate during atrial fibrillation on clinical outcomes in elderly non-valvular atrial fibrillation patients: ANAFIE Registry sub-cohort study.
    J Cardiol. 2022 Nov 22:S0914-5087(22)00282-9. doi: 10.1016/j.jjcc.2022.
    >> Share

  33. UENO H, Imamura T, Tanaka S, Fukuda N, et al
    Left atrial appendage closure for stroke prevention in nonvalvular atrial fibrillation: A current overview.
    J Cardiol. 2022 Nov 15. pii: S0914-5087(22)00277.
    >> Share

  34. CHEN WT, Li CH, Chou YH, Lin WL, et al
    Post-ablation augmentation of skin sympathetic nerve activity predicts a poor outcome of idiopathic ventricular arrhythmias.
    J Cardiol. 2022 Nov 10. pii: S0914-5087(22)00274.
    >> Share

    October 2022
  35. LEIVA O, Jenkins A, Rosovsky RP, Leaf RK, et al
    Predictors of increased risk of adverse cardiovascular outcomes among patients with myeloproliferative neoplasms and atrial fibrillation.
    J Cardiol. 2022 Oct 29. pii: S0914-5087(22)00269.
    >> Share

  36. DING L, Weng S, Zhang H, Yu F, et al
    Novel tissue-pressure sensing technology using a wide-band dielectric imaging system: An in vivo study.
    J Cardiol. 2022;80:319-324.
    >> Share

  37. NIEHUES P, Wegner FK, Wolfes J, Willy K, et al
    Incidence and predictors of cardiac arrhythmias in patients with COVID-19 induced ARDS.
    J Cardiol. 2022;80:298-302.
    >> Share

    September 2022
  38. PATSIOU V, Samaras A, Kartas A, Moysidis DV, et al
    Prognostic implications of adherence to OACs among patients with atrial fibrillation: Insights from MISOAC-AF trial.
    J Cardiol. 2022 Sep 27. pii: S0914-5087(22)00241.
    >> Share

  39. HATORI Y, Sakai H, Hatori N, Kunishima T, et al
    Long-term outcome and risk factors associated with events in patients with atrial fibrillation treated with oral anticoagulants: The ASSAF-K registry.
    J Cardiol. 2022 Sep 12. pii: S0914-5087(22)00220.
    >> Share

    August 2022
  40. MATSUDA S, Kato T, Morimoto T, Taniguchi T, et al
    Atrial fibrillation in patients with severe aortic stenosis.
    J Cardiol. 2022 Aug 23. pii: S0914-5087(22)00206.
    >> Share

  41. AKAO M, Tsuji H, Kusano K, Matsui K, et al
    Clinical characteristics and outcomes of Japanese atrial fibrillation patients with poor medication adherence: A sub-analysis of the GENERAL study.
    J Cardiol. 2022 Aug 16. pii: S0914-5087(22)00200.
    >> Share

  42. KOIZUMI T, Kamada R, Watanabe M, Yokoshiki H, et al
    Predictors of cardiovascular mortality after an electrical storm in patients with structural heart disease.
    J Cardiol. 2022;80:167-171.
    >> Share

    July 2022
  43. YAMAZAKI K, Ishida Y, Sasaki S, Toyama Y, et al
    Characterization of the PRAETORIAN score in Japanese patients undergoing subcutaneous implantable cardioverter-defibrillator implantation.
    J Cardiol. 2022 Jul 25. pii: S0914-5087(22)00160.
    >> Share

    June 2022
  44. INOUE H, Yamashita T, Akao M, Atarashi H, et al
    Corrigendum to 'Prospective observational study in elderly patients with non-valvular atrial fibrillation: Rationale and design of the All Nippon AF In the Elderly (ANAFIE) Registry' [Journal of Cardiology 72 (2018) 300-306].
    J Cardiol. 2022 Jun 29. pii: S0914-5087(22)00154.
    >> Share

  45. HEMMI H, Kataoka N, Imamura T
    Paroxysmal atrial fibrillation as a cause of unexplained syncope.
    J Cardiol. 2022 Jun 17. pii: S0914-5087(22)00139.
    >> Share

  46. YAMASHITA T, Uchiyama S, Atarashi H, Okumura K, et al
    Treatment strategy of dabigatran etexilate following the availability of idarucizumab in Japanese patients with non-valvular atrial fibrillation: J-Dabigatran Surveillance 2.
    J Cardiol. 2022 Jun 15. pii: S0914-5087(22)00096.
    >> Share

  47. FUKUNAGA M, Isotani A, Shirai S, Murakami N, et al
    Initial practice of left atrial appendage closure device in Japan; single-center experience.
    J Cardiol. 2022;79:752-758.
    >> Share

    April 2022
  48. VARNEY JA, Dong VS, Tsao T, Sabir MS, et al
    COVID-19 and arrhythmia: An overview.
    J Cardiol. 2022;79:468-475.
    >> Share

  49. KUNO T, Takahashi M, So M, Egorova NN, et al
    The association of anticoagulation before admission and survival of patients with COVID-19.
    J Cardiol. 2022;79:489-493.
    >> Share

    March 2022
  50. MIYAZAKI S, Miyauchi K, Hayashi H, Yamashiro K, et al
    Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    J Cardiol. 2022 Mar 25. pii: S0914-5087(22)00058.
    >> Share

  51. CHEN WT, Lo LW, Tsai WC, Lin YJ, et al
    Application of dynamic display technology to identify gaps after pulmonary vein isolation in catheter ablation of atrial fibrillation.
    J Cardiol. 2022 Mar 23. pii: S0914-5087(22)00052.
    >> Share

  52. MIYAZAKI Y, Yamagata K, Ishibashi K, Inoue Y, et al
    Paroxysmal atrial fibrillation as a predictor of pacemaker implantation in patients with unexplained syncope.
    J Cardiol. 2022 Mar 12. pii: S0914-5087(22)00049.
    >> Share

  53. OGURA S, Nakamura K, Morita H, Nakagawa K, et al
    Fragmented QRS as a predictor of cardiac events in patients with cardiac sarcoidosis.
    J Cardiol. 2022;79:446-452.
    >> Share

    February 2022
  54. YAMANE T
    Catheter ablation of atrial fibrillation: Current status and near future.
    J Cardiol. 2022 Feb 24. pii: S0914-5087(22)00025.
    >> Share

  55. MORI H, Fukui K, Maeda A, Akashi Y, et al
    Impact of atrial fibrillation and the clinical outcomes in patients with acute myocardial infarction from the K-ACTIVE registry.
    J Cardiol. 2022 Feb 22. pii: S0914-5087(22)00029.
    >> Share

  56. KIDA K, Nabeta T, Ishida M, Shiono T, et al
    D-dimer levels in patients with nonvalvular atrial fibrillation and acute heart failure treated with edoxaban.
    J Cardiol. 2022 Feb 8. pii: S0914-5087(22)00015.
    >> Share

  57. OUCHI K, Sakuma T, Higuchi T, Yoshida J, et al
    Filling defects in the left atrial appendage restricted to the early phase of cardiac computed tomography as a potential risk of left atrial appendage dysfunction.
    J Cardiol. 2022;79:211-218.
    >> Share

  58. NAKAJIMA Y
    Effectiveness and safety of transcatheter left atrial appendage closure.
    J Cardiol. 2022;79:186-193.
    >> Share

    January 2022
  59. CHEN JY, Chen TW, Lu WD
    The HAT2CH2 score predicts neurologic events in patients with cardiac implantable electronic devices without atrial fibrillation.
    J Cardiol. 2022 Jan 8. pii: S0914-5087(21)00385.
    >> Share

  60. MIYAZAKI A, Uemura H
    Perspective of preexcitation induced cardiomyopathy; early septal contraction, and subsequent rebound stretch.
    J Cardiol. 2022;79:30-35.
    >> Share

    December 2021
  61. TAKEUCHI D, Uto K, Inai K, Nagashima Y, et al
    Prominent atrial fibrosis and its correlation with dilated atrium atrial tachyarrhythmia and long after classic Fontan surgery.
    J Cardiol. 2021 Dec 23. pii: S0914-5087(21)00360.
    >> Share

  62. KURAOKA A, Ishizu T, Sato M, Igarashi M, et al
    Left atrial regional strain assessed by novel dedicated three-dimensional speckle tracking echocardiography.
    J Cardiol. 2021;78:517-523.
    >> Share

    November 2021
  63. VALLES E, Marti-Almor J, Grau N, Casteigt B, et al
    Influence of PACE score and conduction disturbances in the incidence of early new onset atrial fibrillation after typical atrial flutter ablation.
    J Cardiol. 2021 Nov 10. pii: S0914-5087(21)00288.
    >> Share

  64. WANG Y, Shao C, Qi L, Tan J, et al
    EphrinB2-RhoA upregulation attenuates sympathetic hyperinnervation and decreases the incidence of ventricular arrhythmia after myocardial infarction.
    J Cardiol. 2021 Nov 5. pii: S0914-5087(21)00290.
    >> Share

  65. BICCIRE FG, Pastori D, Torromeo C, Acconcia MC, et al
    Acute atrial ischemia associates with early but not late new-onset atrial fibrillation in STEMI patients treated with primary PCI: relationship with in-hospital outcomes.
    J Cardiol. 2021;78:368-374.
    >> Share

  66. LAO N, Lim J, Bashir H, Mahalwar G, et al
    Incidence of Atrioventricular Blocks and its Association with In-Hospital Mortality and Morbidity in Patients with Coronavirus Disease 2019.
    J Cardiol. 2021 Nov 1. pii: S0914-5087(21)00305.
    >> Share

    October 2021
  67. NAGANO T, Yasuoka R, Tanaka M, Maruyama M, et al
    A proposed interval for evaluation of renal function during anticoagulation therapy using direct oral anticoagulants in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 29. pii: S0914-5087(21)00244.
    >> Share

  68. OBAYASHI Y, Miyake M, Amano M, Kitai T, et al
    Impact of mitral versus aortic bioprosthetic valve position on thromboembolism and bleeding risk in patients with atrial fibrillation.
    J Cardiol. 2021 Oct 26. pii: S0914-5087(21)00273.
    >> Share

  69. TU T, Li B, Li X, Zhang B, et al
    Dietary omega-3 fatty acids reduced atrial fibrillation vulnerability via attenuating myocardial endoplasmic reticulum stress and inflammation in a canine model of atrial fibrillation.
    J Cardiol. 2021 Oct 23. pii: S0914-5087(21)00207.
    >> Share

  70. WEI F, Ren W, Zhang X, Wu P, et al
    miR-425-5p is negatively associated with atrial fibrosis and promotes atrial remodeling by targeting CREB1 in atrial fibrillation.
    J Cardiol. 2021 Oct 20. pii: S0914-5087(21)00253.
    >> Share

  71. FUKUSHIMA S, Suzuki K, Kawamoto N, Kakuta T, et al
    Launching minimally invasive stand-alone maze procedure for atrial fibrillation.
    J Cardiol. 2021 Oct 5. pii: S0914-5087(21)00256.
    >> Share

  72. OKADA M, Inoue K
    Catheter ablation of atrial fibrillation with left ventricular systolic dysfunction: Potential approach to the cause of heart failure-authors' reply.
    J Cardiol. 2021;78:347-348.
    >> Share

    September 2021
  73. IWAHASHI N, Kirigaya J, Abe T, Horii M, et al
    Clinical usefulness of left ventricular outflow tract velocity time integral for heart failure with reduced ejection fraction with rapid atrial fibrillation during landiolol treatment.
    J Cardiol. 2021 Sep 23. pii: S0914-5087(21)00242.
    >> Share

  74. KATO A, Sato J, Yoshii K, Yoshida S, et al
    The mid-term outcome of Fontan conversion compared with primary total cavopulmonary connection.
    J Cardiol. 2021;78:213-218.
    >> Share

    August 2021
  75. KANAI M, Yagishita D, Shoda M, Ejima K, et al
    Clinical outcomes of upgrade to versus de novo cardiac resynchronization therapy in mild heart failure patients with atrioventricular block.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00195.
    >> Share

  76. UKITA K, Egami Y, Kawamura A, Nakamura H, et al
    Clinical impact of very early recurrence of atrial fibrillation after radiofrequency catheter ablation.
    J Cardiol. 2021 Aug 20. pii: S0914-5087(21)00199.
    >> Share

    July 2021
  77. TOHOKU S, Bordignon S, Chen S, Bologna F, et al
    Validation of lesion durability following pulmonary vein isolation using the new third-generation laser balloon catheter in patients with recurrent atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00167.
    >> Share

  78. LAI SW
    Urine dipstick proteinuria and atrial fibrillation.
    J Cardiol. 2021 Jul 28. pii: S0914-5087(21)00179.
    >> Share

  79. SAIRAKU A, Morishima N, Amioka M, Maeda J, et al
    Does atrial fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era.
    J Cardiol. 2021 Jul 10. pii: S0914-5087(21)00165.
    >> Share

    June 2021
  80. RAMESH T, Lee PYK, Mitta M, Allencherril J, et al
    Intravenous magnesium in the management of rapid atrial fibrillation: A systematic review and meta-analysis.
    J Cardiol. 2021 Jun 20. pii: S0914-5087(21)00151.
    >> Share

  81. TAKAHIRA H, Kajiyama T, Kondo Y, Nakano M, et al
    Pathophysiological background and prognosis of common atrial flutter in non-elderly patients: Comparison to Atrial Fibrillation.
    J Cardiol. 2021 Jun 14. pii: S0914-5087(21)00132.
    >> Share

  82. IMAMURA T
    Cardiac reverse remodeling following catheter ablation of atrial fibrillation.
    J Cardiol. 2021 Jun 10. pii: S0914-5087(21)00134.
    >> Share

  83. KUSUNOSE K, Takahashi H, Nishio S, Hirata Y, et al
    Predictive value of left atrial function for latent paroxysmal atrial fibrillation as the cause of embolic stroke of undetermined source.
    J Cardiol. 2021 Jun 9. pii: S0914-5087(21)00129.
    >> Share

  84. IWANO T, Toda H, Nakamura K, Shimizu K, et al
    Preventative effects of bisoprolol transdermal patches on postoperative atrial fibrillation in high-risk patients undergoing non-cardiac surgery: A subanalysis of the MAMACARI study.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00113.
    >> Share

  85. NISHIKIMI T, Nakagawa Y
    Potential pitfalls when interpreting plasma BNP levels in heart failure practice.
    J Cardiol. 2021 Jun 1. pii: S0914-5087(21)00114.
    >> Share

  86. ABE Y, Takahashi Y, Shibata T
    A new disease entity: Atrial functional mitral regurgitation.
    J Cardiol. 2021;77:565-569.
    >> Share

    May 2021
  87. TSAI YN, Cheng WH, Chang YT, Hsiao YW, et al
    Mechanism of angiotensin receptor-neprilysin inhibitor in suppression of ventricular arrhythmia.
    J Cardiol. 2021 May 28. pii: S0914-5087(21)00108.
    >> Share

    April 2021
  88. MARUYAMA M, Yasuoka R, Nagano T, Nakazawa G, et al
    Impact of atrial fibrillation/flutter on outcomes of patients with implantable cardioverter defibrillators: A sub-analysis of the Nippon Storm study.
    J Cardiol. 2021 Apr 30. pii: S0914-5087(21)00091.
    >> Share

  89. OKISHIGE K, Yamauchi Y, Nagase S, Kusano K, et al
    Transcatheter cryo-ablation of septal accessory pathways, multicenter observational study in Japan.
    J Cardiol. 2021;77:380-387.
    >> Share

  90. ASHER E, Abu-Much A, Bragazzi NL, Younis A, et al
    CHADS2 and CHA2DS2-VASc scores as predictors of platelet reactivity in acute coronary syndrome.
    J Cardiol. 2021;77:375-379.
    >> Share

  91. TOPAZ G, Ben-Zvi E, Pereg D, Kitay-Cohen Y, et al
    Prediction of acute-coronary-syndrome using newly-defined R2-CHA2DS2-VASc score among patients with chest pain.
    J Cardiol. 2021;77:370-374.
    >> Share

    March 2021
  92. INOUE K, Hirao K, Kumagai K, Kimura M, et al
    Long-term efficacy and safety of anticoagulation after atrial fi brillation ablation: data from the JACRE registry.
    J Cardiol. 2021;77:263-270.
    >> Share

    February 2021
  93. WILLY K, Dechering DG, Reinke F, Bogeholz N, et al
    The ECG in sarcoidosis - a marker of cardiac involvement? Current evidence and clinical implications.
    J Cardiol. 2021;77:154-159.
    >> Share

  94. KISHIMA H, Mine T, Fukuhara E, Ishihara M, et al
    Left ventricular stiffness assessed by diastolic Wall strain predicts asymptomatic atrial high-rate episodes in patients with pacemaker implantation.
    J Cardiol. 2021;77:195-200.
    >> Share

  95. CHEN JY, Lu WD
    Duration of atrial high-rate episodes and CHA2DS2-VASc score to predict cardiovascular and cerebrovascular events in patients with dual chamber permanent pacemakers.
    J Cardiol. 2021;77:166-173.
    >> Share

    August 2020
  96. MIZOBUCHI A, Osawa K, Tanaka M, Yumoto A, et al
    Detrended fluctuation analysis can detect the impairment of heart rate regulation in patients with heart failure with preserved ejection fraction.
    J Cardiol. 2020 Aug 18. pii: S0914-5087(20)30274.
    >> Share

    May 2020
  97. WILLY K, Reinke F, Bogeholz N, Ellermann C, et al
    The role of entirely subcutaneous ICD systems in patients with dilated cardiomyopathy.
    J Cardiol. 2020;75:567-570.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016